Mary Laughlin

Mary Laughlin has a diverse work experience in the fields of proposal management, contracts, project management, and leadership. Mary currently works at Cytel, where they are responsible for the development and management of proposals, contracts, and work orders. Mary's role involves reviewing clinical study specifications, liaising with operational teams, and ensuring on-time delivery.

Prior to their current role, Mary worked at ICON Specialty Labs (formerly MolecularMD) as a Senior Contract Analyst and Clinical Research Proposal and Contract Manager. Mary managed contracts from proposal to execution, collaborated with cross-disciplinary teams, and provided subject matter expertise on molecular assay development and validation for clinical trials.

Mary also has experience at Oasis Diagnostics Corporation, where they served as the Director of Operations and Project Manager. Mary'sresponsibilities included overseeing manufacturing, new product development, and implementing quality control procedures. Mary also contributed to the design and commercialization of molecular diagnostics products.

Before joining Oasis Diagnostics, Mary worked as a Senior Scientist at Diabetomics, where they played a key role in the research, development, and validation of new products. Mary'swork included co-inventing a saliva collection device for DNA isolation and managing projects within expected timeframes.

Overall, Mary Laughlin's work experience showcases their expertise in proposal and contract management, project leadership, and product development in the healthcare and life sciences industries.

Mary Laughlin has a strong educational background in the field of biology and genetics. Mary obtained a Bachelor of Science degree in Biology, with a minor in Chemistry, from California State Polytechnic University-Pomona. Mary then pursued further education at the University of Washington, where they focused on Biotechnology Project Management. Although the exact duration of their studies at the University of Washington is not known, they did obtain a certification in Biotechnology Project Management from that institution. Mary Laughlin also pursued a Ph.D. in Genetics and Cell Biology from Washington State University, although the specific details of their enrollment are not provided.